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Background: The Gene Ontology (GO) facilitates the description of the action of gene products in a biological
context. Many GO terms refer to chemical entities that participate in biological processes. To facilitate accurate and
consistent systems-wide biological representation, it is necessary to integrate the chemical view of these entities
with the biological view of GO functions and processes. We describe a collaborative effort between the GO and the
Chemical Entities of Biological Interest (ChEBI) ontology developers to ensure that the representation of chemicals
in the GO is both internally consistent and in alignment with the chemical expertise captured in ChEBI.
Results: We have examined and integrated the ChEBI structural hierarchy into the GO resource through
computationally-assisted manual curation of both GO and ChEBI. Our work has resulted in the creation of
computable definitions of GO terms that contain fully defined semantic relationships to corresponding chemical
terms in ChEBI.
Conclusions: The set of logical definitions using both the GO and ChEBI has already been used to automate
aspects of GO development and has the potential to allow the integration of data across the domains of biology
and chemistry. These logical definitions are available as an extended version of the ontology from http://purl.
obolibrary.org/obo/go/extensions/go-plus.owl.Background
New high-throughput technologies are being used to
generate large quantities of data detailing interactions
between genes, molecules and biological systems. There
is a critical need for informatics tools that can integrate
both chemical and biological knowledge with these
datasets to gain a deeper understanding of biological
networks [1] and to stimulate drug discovery [2]. One
informatics resource that has transformed the analysis of
large biological datasets is the Gene Ontology (GO) [3],
which provides a computable description of the func-
tional aspects of an increasing number of genes and
gene products spanning a diverse range of species. The
GO is used by gene product annotators to assign attri-
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reproduction in any medium, provided the orbased on experimental reports in the primary literature
[4-12]. These annotation sets are used for large dataset
interrogation to determine similarities and differences in
the attributes of gene products within those datasets.
For example, the GO has been used to look into the
function of genes that may contribute to adaptation of
humans to high altitudes as well as to find correlations
between gene function and diseases or disorders such as
cancer or autism [13-16].
At the core of the GO is a collection of over 36,000
terms, connected by more than 67,000 relationships. For
ontology curators to maintain accuracy and consistency
in a structure this large and complicated, it is critical to
incorporate automated methods to check for integrity
and to help build the ontology graph [17-19]. To this
end, the GO has been adding computable definitions for
many of its terms [19]. Automatic reasoners can then
use these logical definitions to check for logical inconsist-
encies in the graph, to infer additional relationships, and
to automatically classify new terms within the hierarchy.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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definitions include components both from within the GO
and from specialized external ontologies, as it allows for
the resources to build on the information contained within
the other ontologies.
A complementary resource for chemists is ChEBI
(Chemical Entities of Biological Interest). ChEBI consists
of approximately 30,000 terms organized along similar
principles to the GO [20]. ChEBI acts as a reference for
chemical entities across multiple domains and includes
in its repertoire a wide range of entities from the sub-
atomic scale to complex polymers. A growing number of
bioinformatics resources are utilizing both the GO and
ChEBI as part of a substantial effort to integrate a large
set of biological ontologies for community use [21-26].
The GO and ChEBI have been constructed largely for
different purposes and, until recently, have only been
loosely connected. Previous efforts to align information
between these resources have used semantic similarity
and string matching methods [27,28]. Here we describe
the first stages of a process to fully dovetail the two on-
tologies, achieved through a combination of automated
tools and the considerable efforts of domain experts in
biology, biochemistry and chemistry working to recon-
cile multiple organizational views to achieve an inte-
grated whole. As a result of this work, we have new
interoperable versions of each of these two ontologies
and a collection of relationships that bridge them. This
combined resource has already been used to automatic-
ally generate and classify new terms within the GO using
a Web Ontology Language (OWL) representation of the
GO in conjunction with some specifically designed tools
like the OBO Ontology Release Tool (Oort, http://code.
google.com/p/owltools/wiki/OortIntro) and TermGenie
(http://go.termgenie.org/, Dietze et al., manuscript in pre-
paration), which make use of powerful OWL reasoners
such as ELK and HermiT [29,30]. We hope that this
approach and the lessons learned during our collabor-
ation will provide other ontology developers with a basic
roadmap to integrating other ontologies more efficiently.
Results and discussion
Inherent GO chemical ontology
Before comparing the GO to an external chemical ontol-
ogy, the inherent chemical representations in the GO
were checked for internal consistency. We identified in-
consistencies that existed within the GO using a com-
bination of automated and manual methods. First, we
generated a graph in which the chemicals in the GO
were separated from processes and functions and repre-
sented as stand-alone chemicals with relationships that
followed the is_a hierarchy in the GO (Figure 1). This
allowed us to extract the implicit chemical ontology
embedded within the GO.We determined that there were eight sub-ontologies
in the GO where chemical names were frequently used:
‘response to chemical stimulus’ (GO:0042221), ‘transport’
(GO:0006810), ‘transporter activity’ (GO:0005215), ‘meta-
bolic process’ (GO:0008152), ‘biosynthetic process’ (GO:00
09058), ‘catabolic process’ (GO:0009056), ‘catalytic activity’
(GO:0003824) and ‘binding’ (GO:0005488), as well as
the sub-ontologies representing types of regulation of
these processes and functions. When possible, these
chemical names were cross-referenced to the chemicals
in ChEBI. Relationships in this ‘GO chemical ontology’
represented the union of all of the is_a relationships for
each sub-ontology of the GO.
Previous work in deductive and abductive reasoning
over relationships asserted between terms from the GO
and other ontologies has revealed a large number of in-
consistencies within the GO itself. For example, incon-
sistent representations of chemicals were found among
biological processes and molecular functions (Figure 2)
[31]. This type of error and inconsistency identified in the
GO’s representation of chemicals during manual review
were corrected. This corrected GO chemical ontology was
then used as a template for coordination with ChEBI.
Differences between the GO and ChEBI
Adjustments resulting in concordance of the implicit GO
chemical ontology with the ChEBI ontology required two
processes. Initially, cross-references between the GO and
ChEBI were generated by a string-matching algorithm
between GO terms and synonyms and ChEBI terms and
synonyms. Those cross-references were then checked
manually during the curation of the GO chemical on-
tology. Terms that were not cross-referenced—that is, the
implicitly represented chemicals in the GO terms for
which corresponding terms in ChEBI were not found—fell
into three categories:
1. Terms in the GO chemical ontology that referred to
existing terms in the ChEBI ontology, but for which
the matches were not detected automatically due to
naming differences. During this analysis both term
names and synonyms are utilized to determine
matches. For example, the GO chemical ‘butanoic
acid’ should be cross-referenced to the ChEBI entry
‘butyric acid’ (CHEBI:30772). These terms were
identified and cross-referenced manually.
2. Chemicals in GO terms that were not represented in
ChEBI. 283 temporary terms with internal identifiers
were created to represent these chemicals, which have
subsequently been incorporated into ChEBI, where
appropriate, via the ChEBI online submission tool [20].
3. Terms that represented axes other than that of
structural chemical classification, e.g., function,
disposition or role axes of classification.
Figure 1 An example of a portion of the GO chemical ontology representing the inherent chemical ontology within the GO. The entire
ontology consists of the union of all possible inter-chemical relationships inferred by GO terms. This ontology was used as an initial step for
curators to examine how chemicals were represented throughout the ontology.
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In addition to cases where chemicals implicitly repre-
sented in GO terms were not represented in ChEBI, we
also found cases where the chemicals were represented
in both the GO and ChEBI, but the representation ofFigure 2 Example of inconsistencies of chemical representations with
representation of ‘glucose-6-phosphate’ in the transport portion of the b
‘glucose’ AND a ‘hexose phosphate’ B) The representation of ‘glucose-6
graph. ‘Glucose-6-phosphate’ is inherently a ‘hexose phosphate’ but NOchemicals did not match due to differences in the terms
themselves or in the hierarchical relationships. These
discrepancies reflect deeper differences in the use of
chemical terminology and classification between biolo-
gists and chemists.in the GO. Arrows represent is_a relationships between terms. A) The
iological process graph. ‘Glucose-6-phosphate’ is inherently both a
-phosphate’ in the transporter portion of the molecular function
T a ‘glucose’. Only relevant terms and their relationships are shown.
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The use of plurals in class names is not generally recom-
mended in ontology construction because it can introduce
ambiguity in the meaning of a term and cause problems
with string matching when used in conjunction with other
ontologies [32]. However, ChEBI uses plural term names
to designate families of structurally related molecules
that are named after a specific molecule from which
they are formally derived. Plural names used in this
way follow International Union of Pure and Applied
Chemistry (IUPAC) recommendations and are therefore
the accepted way for chemists to refer to these families
of structures. For example, ‘pyridines’ (CHEBI:26421)
encompasses all molecules that contain a pyridine ring,
whereas ‘pyridine’ (CHEBI:16227) specifically represents
the molecule that contains a pyridine ring and has the
formula C5H5N. In vernacular English usage, however, a
singular noun such as ‘pyridine’ can be ambiguous between
the specific sense, corresponding to either ‘pyridine’ in
ChEBI (CHEBI:16227) and to the EXACT reading in the
notation of Corbett et al [33], or the collective sense corre-
sponding to ‘pyridines’ in ChEBI (CHEBI:26421) and the
CLASS reading. As a result of this ambiguity, the GO
contained definitions that refer to both CLASS readings,
as in ‘phenol metabolic process’ (GO:0018958), and
to EXACT readings, e.g. ‘benzene metabolic process’
(GO:0018910).
We decided to reconcile this difference in nomen-
clature by renaming the plural terms as 'X-containing
compound' for GO chemicals. In the example above,
GO:0018958 is renamed 'phenol-containing compound
metabolic process'. Terms of equivalent meaning to the
plural terms in ChEBI can now easily be created in the
GO. So far, 86 terms in the GO have been renamed to
reflect the new convention.
Case 2: Representation of complex molecules such
as nucleotides and nucleosides
The representation of complex molecules such as nucle-
otides, nucleosides or liposaccharides was another area
that posed problems for the coordination of ChEBI and
the GO. The issue arose because there are two main
strategies used by chemists to classify molecules. The
natural product strategy predates the acceptance of the
atomic theory by organic chemists and involves classifying
molecules according to their biological histories; hence
alkaloids were those nitrogenous molecules extracted from
plants, terpenoids are those molecules that have been
derived from terpene molecules by chemical modification
and so forth. They share a family resemblance, although
there is no single structural signature for a given class
that allows for its classification. The functional strategy,
conversely, involves identifying functional groups, such
as carboxy groups or carbon–carbon double bondswithin a molecule and assigning the molecule to a func-
tional class such as, in this case, the carboxylic acids or
the olefins, respectively. The choice of the name 'func-
tional' is significant because the functional groups pick
out those parts of a molecule that are disposed to react
in a particular way. But because there is no limit to the
number of functional groups within a molecule, there
is in principle no limit to the number of functional
classes to which a molecule can belong. From a struc-
tural point of view, describing these complex chemicals
is similar to the story of the blind men and the ele-
phant, where each man describes the elephant as some-
thing different depending upon the part he is touching.
That is, classification is based on specific parts of the
molecule that are attached at different positions. For
example, a nucleotide that contains a nucleobase, a
sugar and at least one phosphate group would be de-
scribed as a carbohydrate by a carbohydrate biochemist,
who is primarily concerned with the reactivity of the
carbohydrate moiety of the molecule, whereas general
organic chemists might classify it as a phosphoric ester.
Both of the above classifications are correct chem-
ically, but they can lead to incorrect inferences when
extrapolated to the process hierarchy in the GO. Con-
sider ‘nucleotide metabolic process’ (GO:0009117), ‘carbo-
hydrate metabolic process’ (GO:0005975) and ‘phosphate
metabolic process’ (GO:0006796) in the GO. If ‘nucleotide
metabolic process’ (GO:0009117) were classified as both
is_a ‘carbohydrate metabolic process’ (GO:0005975) and
is_a ‘phosphate metabolic process’ (GO:0006796) to paral-
lel the structural hierarchy in ChEBI, then the process
that results in the addition of a phosphate group to a
nucleotide diphosphate would be misleadingly classified
as is_a ‘carbohydrate metabolic process’ (GO:0005975).
This is misleading because, since the carbohydrate portion
of the nucleotide is not being metabolized, biologists
would not typically consider this to be a carbohydrate
metabolic process.
To avoid this kind of misleading inference, the con-
stituent parts of a nucleotide in ChEBI are now repre-
sented using has_functional_parent assertions instead of
explicitly asserted is_a relationships. ChEBI uses the
has_functional_parent relationship to denote the rela-
tionship between two molecular entities (or classes of
entities), one of which possesses one or more character-
istic groups and from which the other can be derived
by functional modification. Thus a nucleoside will be
defined as ‘an N-glycosyl compound that has both a
nucleobase and either a ribose or deoxyribose as func-
tional parents’. As an extension, both ChEBI and the
GO will define a nucleotide as ‘a phosphate ester that
has a nucleoside moiety AND has at least one phos-
phate moiety attached to the C-5 carbon of the ribose
or deoxyribose moiety’.
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in the GO and ChEBI
Another area where the GO chemical ontology and ChEBI
failed to agree was in the representation of acids and their
conjugate bases. ChEBI has a detailed representation of
acids and conjugate bases with the inclusion of ‘is_con-
jugate_acid_of ’ and ‘is_conjugate_base_of ’ relationships in
the ontology. So ‘carboxylic acid’ is_conjugate_acid_of
‘carboxylic acid anion’ and ‘carboxylic acid anion’ is_
conjugate_base_of ‘carboxylic acid’. In contrast, in the
GO, acids and their conjugate bases are often conflated.
For example, in the GO ‘nitrilotriacetate metabolic pro-
cess’ is_a ‘carboxylic acid metabolic process’ (Figure 3).
The implicit GO chemical ontology therefore states that
‘nitrilotriacetate’ is_a ‘carboxylic acid’. From a chemical
viewpoint, this is incorrect. ‘Nitrilotriacetate’ is the con-
jugate base of a member of the class ‘carboxylic acid’,Figure 3 An illustration of the combined usage of acid/
conjugate base terminology in the GO. In the GO,
‘nitrilotriacetate metabolism’ is a type of ‘tricarboxylic acid
metabolism’. This inherently states that nitrilotriacetate is a type of
tricarboxylic acid. The underlying structure of the ontology now
represents ‘nitrilotriacetate metabolism’ as ‘nitrilotriacetic acid’
metabolism and the metabolism of its conjugate bases. Only
relevant terms and their relationships are shown.‘nitrilotriacetic acid’. This inaccurate representation in the
GO reflects the conflated use of nomenclature for acids
and their conjugate bases in the biological community
because these molecules often readily interconvert as
they participate in biological processes. To resolve this
issue we have decided to combine the terminology for
oxoacids and their conjugate bases in the GO, and
make these combined entities equivalent to the union
of the acid with its conjugate base or bases in an in-
ternal file, BioChEBI (see Methods below). This reflects
the convention that when ‘acids’ are referred to in the
biochemical literature, they most often refer to mole-
cules that are playing the role of an acid and as such
are deprotonated at physiological pH. It also allows for
the integration of the GO chemical ontology, which is
blind to the conjugate acid/base distinction, with a sin-
gle is_a hierarchy in ChEBI.
A similar strategy could also be used for terms in
other areas of ChEBI where two chemicals are related to
each other using a non-is_a relationship. For example
tautomers in ChEBI are distinguished by the relationship
is_tautomer_of and could be treated in a similar manner
as the acids and bases. However, we did not find it
necessary to implement this strategy since we did not
find a confusion of tautomeric structures in the inherent
GO chemical structure. Similarly stereoisomers and salt
forms did not present a problem. Stereoisomers were
already distinguished in the GO and the corresponding
ChEBI terms were mapped 1:1.
Logical definitions for GO terms using ChEBI terms
GO terms were deconstructed and represented as inter-
sections between GO terms and relationships to ChEBI
terms. For example, ‘carbohydrate binding’ (GO:0030
246) is represented as the intersection of the generic
GO molecular function class ‘binding’ (GO:0005488) and
a has_input relationship to the ChEBI class ‘carbohydrate’
(CHEBI:16646), while ‘carbohydrate metabolic process’
(GO:0005975) is represented as the intersection of the
generic GO biological process class ‘metabolic process’
(GO:0008152) and a has_input relationship to the ChEBI
class ‘carbohydrate’ (CHEBI:16646). As of mid-October
2012 there are 4,403 terms in the GO that have been
defined using ChEBI chemical entities (Table 1).
The logical definitions of GO terms that reference che-
mical entities in ChEBI are maintained in an extended
version of the ontology (http://purl.obolibrary.org/obo/go/
extensions/go-plus.owl). When a new GO term is re-
quested that involves a chemical entity not currently de-
scribed in ChEBI, that chemical entity is first given to
ChEBI to be reviewed for inclusion. Only when the new
class is subsequently added to ChEBI is the corresponding
GO term created. It will not be necessary to incorporate
every ChEBI term into the GO hierarchy because many
Table 1 Terms in the GO that refer to chemicals
Term type Number of terms with logical
definitions that refer to ChEBI
chemical secretion 38
chemical binding 345
chemical transport 466
chemical metabolic process 1,120
chemical biosynthetic process 990
chemical catabolic process 870
response to chemical 196
chemical homeostasis 33
chemical transporter activity 324
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natural biological processes. For example, the ChEBI term
‘nucleoside triphosphate analog’ (CHEBI:37413) which
includes many chemicals used in biochemical inquiry, but
will likely not be incorporated into the GO because they
do not play roles in natural biological processes.
Conclusion
In this manuscript we have described the process of re-
solving two independently developed ontologies for the
purpose of knowledge integration and sharing. The inte-
gration of ChEBI and the GO benefits both ontologies
since it allows for the consistent and accurate represen-
tation of chemicals in the GO, and for the chemicals
represented in ChEBI to be placed in the natural bio-
logical contexts of GO processes. This interoperability of
ontologies is one of the primary goals of the coordinated
development of the group of ontologies that make up
the OBO Foundry [21].
As a result of this work and the close ties that were
established between the GO and ChEBI during this
process, all new GO terms that involve the transport,
metabolism, response to chemical entities and homeo-
stasis can be added to the ontology via a new web-based
tool called TermGenie (http://go.termgenie.org/, Dietze
et al., manuscript in preparation). TermGenie is a tem-
plate-based, reasoner-assisted term-generation tool. An-
notators can generate these terms directly by selecting
the broad GO category (e.g. transport, biosynthesis) and
any term from ChEBI. Missing ChEBI entities need to be
requested from ChEBI before proceeding. Labels, syno-
nyms and textual definitions are generated automatically,
using the grammar described above. The new term is
placed automatically into the GO subsumption hierarchy
using the ELK reasoner [29] without the need for cur-
ator review.
We identified various underlying reasons for most of
the discrepancies between the inherent GO chemical
ontology and ChEBI. Many of the challenges in makingseparate ontologies such as the GO and ChEBI parallel
result from different fields of study having different
viewpoints about the importance of certain characteris-
tics that are represented in their terms and about the
axis of classification that they use.
Another issue we encountered in the alignment of
the GO and ChEBI is classification by biological role.
ChEBI contains a ‘biological role’ hierarchy that is separ-
ate from its structural, ‘chemical entity’ hierarchy. This
hierarchy includes terms such as ‘hormone’ and ‘toxin’,
and chemical entities are linked to these roles via the
has_role relationship. Many of these biological roles are
also referenced by the GO in terms such as ‘hormone
secretion’. However, unlike the structural classification
axis, using the ‘biological role’ hierarchy from ChEBI
for the classification of terms within the GO subsumption
hierarchy is not straightforward because roles are context-
specific. For example, in ChEBI, ‘acetylcholine’ has_role
‘neurotransmitter’ and has_role ‘hormone’. This is be-
cause in the brain acetylcholine can act as a neurotrans-
mitter, while in other tissues it can act as a hormone. If
this role relationship were to be propagated in the GO,
that is, asserting ‘acetylcholine secretion’ is_a ‘neurotrans-
mitter secretion’, the GO would be in error for instances
where acetylcholine was secreted but was acting as a hor-
mone. The alignment of the classification of the GO with
the ChEBI roles will be undertaken in a separate project.
The GO and ChEBI also differ when chemicals in the
GO are classified based on a process in which they are
involved. For example, in the GO there are terms like
‘aspartate family amino acid biosynthetic process’ that
represent the metabolism of amino acid families. These
families are not based on the chemical similarities of the
amino acids in them, but instead are grouped because
they share similar biosynthetic pathways. Participation in
related pathways is not essentially a structural feature of
the molecules involved, and these processes cannot be
represented by the chemical structural hierarchy of ChEBI.
However, neither do such groupings easily correspond
to ChEBI role terms, since the chemicals are not neces-
sarily active in the pathways involved, as they might,
for example, be created by the relevant pathway, and be
otherwise quite inert themselves with respect to the op-
eration of the pathway. These pathway-derived chem-
ical classifications will remain in the GO, and for the
time being will not be cross-referenced with ChEBI,
although such cross-referencing could constitute a task
for the future.
We have described here a generic approach to integrat-
ing two ontologies that will be used for future projects
coordinating the GO with other external ontologies. Be-
fore examining relationship concordance, ontology terms
should be compared to ensure that the entities that are
common to the two ontologies represent the same things
Table 2 Initial rules for creation of logical definitions
of GO terms
Term Format Term Genus Relationship to Chemical (X)
X metabolic
process
metabolic
process
has_participant some X
X biosynthetic
process
biosynthetic
process
has_output some X
X catabolic
process
catabolic
process
has_input some X
X transport transport transports_or_maintains_localization_of
some X
response to X response to
stimulus
has_input some X
X binding binding has_input some X
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in the ontology whose terms are being formally defined
are explicitly represented in the external ontology whose
terms are being used in the definitions. Next, systematic
differences in the construction rationale of the ontologies
should be identified and a rational strategy should be put
into place where those differences will be retained. Finally,
coordinated curation should be used to identify or ques-
tion relationship differences in the two ontologies. The
final process is continuous and mechanisms should be put
into place that will allow inconsistencies that crop up to
be resolved.
This work is the first part in the integration of ChEBI
and the GO. The next stage will be to describe the enzym-
atic reactions in the GO in terms of the ChEBI entities
that participate in them. For example, the molecular
function ‘aspartate dehydrogenase activity’ is defined
as ‘Catalysis of the reaction: L-aspartate + H2O + NAD
(P)+ = oxaloacetate + NH3 + NAD(P)H + H
+’. We intend
to leverage the data in Rhea, a manually curated reaction
database in which all reaction participants are ChEBI
entities [34], to create the logical definitions of GO
molecular functions. These definitions will allow us to
classify enzymatic reactions automatically based on the
chemicals that participate in them; to make better links
between biological processes and the reactions that are
their parts; and to import new, manually curated reactions
directly from Rhea into the GO, and allow them to be
automatically classified.
Methods
Automatic generation of description logic definitions
To identify the chemical entities referenced by GO terms,
we automatically scanned the labels and synonyms for
GO terms using the Obol tool [35], looking specifically
for references to chemical terms either named in ChEBI
or contained within ChEBI’s extensive synonym list. Che-
mical terms referenced in the GO that were not yet
present in ChEBI were identified by manual review of the
relevant branches of the ontology (Table 2).
For each match, we generated a description logic
equivalence axiom of the form:
<GO class> EquivalentTo: <Core GO class> <Relation-
ship> some <Chemical>
For example, the GO class with label ‘xanthine biosyn-
thetic process’ was parsed to generate an equivalent class
expression ‘biosynthetic process’ and has_output some
‘xanthine’.s
If no chemical entity with the name or synonym ‘X’
could be found in ChEBI, we generated a new class and
requested the respective ChEBI entry using the ChEBI
web application for term requests (https://www.ebi.ac.
uk/chebi/submissions/login). ChEBI curators reviewed
requests and either accepted the new entry, added asynonym to an existing ChEBI record or initiated discus-
sion with a GO curator for clarification of the request.
These equivalence axioms were maintained as a separate
OBO-format “bridge” ontology.
Making the inherent GO chemical ontology consistent
Initial analysis revealed large disparities not only be-
tween the implicit chemical entity hierarchy in the GO
and ChEBI, but also within the GO. Therefore we first
attempted to achieve internal consistency within the
GO, and then proceeded to the larger task of consistency
with ChEBI. To do this, we generated a new ontology
called ‘GOCHE (GO CHEmicals)’ that used a set of 945
chemical entity classes identified by Obol arranged in a
hierarchy determined by relationships in the GO. At this
stage we did not yet refer to the ChEBI hierarchy, as the
goal was first to reconstruct the implicit chemical classi-
fication in the GO and then to compare with ChEBI.
GOCHE was examined and manually edited using the
OBO-Edit tool [36]. Chemical term names were made
internally consistent within the GO, and ChEBI identi-
fiers were used as the IDs for the chemical terms of the
GO chemical ontology. This allowed us to identify the
GO chemicals that either needed to be added to ChEBI
or resolved with existing ChEBI terms. Chemicals that
were missed by Obol but identified during manual review
were also added to GOCHE. We then removed all non-
structural classifications from the representation of GO
chemicals. Next, GO terms were manually inspected and
is_a relationships between chemical-containing terms in
the GO were added to the GO chemical ontology. Incor-
rect relationships were corrected as they were identified.
Identifying and resolving differences between the GO
and ChEBI
Initially, the GO and ChEBI were compared by simultan-
eously visualizing the GO chemical ontology and ChEBI
in OBO-Edit and distinguishing GO chemical is_a rela-
tionships from ChEBI relationships (Figure 4). Manual
Figure 4 An example of the combined representation of ChEBI and the GO chemical ontology using OBO-Edit. These graphical displays
were used by ontology curators to identify and resolve representation differences between ChEBI and the GO. In this example aldoxime is a
nitrogen compound in the GO, but it is not in ChEBI. Oxime is a term in ChEBI that does not exist in the GO. Only relevant terms and their
relationships are shown.
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inconsistencies. Errors where the GO had incorrect or
missing relationships were fixed in the GO chemical on-
tology and suspected errors in ChEBI were reported to
ChEBI. Next, we used the OBO-Edit reasoner to auto-
matically construct a subsumption hierarchy for the sub-
ontologies in the GO that reference chemical entities. This
was compared with the existing manually asserted hier-
archy. We asserted new links in the GO where suggested
by the reasoner and where there was agreement amongst
curators. In cases where the curators disagreed with the
reasoner, we first manually examined the computable
definition for problems. If this definition proved to be
correct, then the root cause was a disagreement between
ChEBI and the implicit chemical ontology in the GO. In
these cases the results were fed back to a wider group for
discussion. We also checked for cases where an asserted
is_a link in the GO hierarchy could not be recapitulated
by reasoning. These cases arose when a GO editor tried to
represent information beyond what could be reasonably
inferred directly from ChEBI, and were manually exam-
ined and resolved by either deletion or the suggestion of
an added relationship to ChEBI.
Creation of BioChEBI
To handle certain modeling differences between the GO
and ChEBI, we created and maintain BioChEBI (http://
purl.obolibrary.org/obo/go/extensions/bio-chebi.owl). Thisontology imports ChEBI and contains special rules that
allow acids and their conjugate bases to be treated as
equivalent within the context of in-vivo biological pro-
cesses. These rules are encoded as OWL general concept
inclusion axioms (GCIs) [37], special constructs that spe-
cify relationships between broad classes of structures. For
example, the GO does not distinguish between citric acid
and its three deprotonated forms: citrate(1-), citrate(2-),
citrate(3-). In contrast, ChEBI has separate entries for each
and links these using ‘is conjugate base of ’ and ‘is conju-
gate acid of ’ relations. BioChEBI provides GCIs stating
that any biological process that takes ‘citrate acid’ as an in-
put is equivalent to one that takes ‘citrate(1-)’, or one that
takes ‘citrate(2-), and so on.
The GCIs for logical definitions containing the ‘has in-
put’, ‘has output’ and ‘transport’ in BioChEBI are gener-
ated by the following pseudocode:
FOR each Class X and Y
WHERE
X is SubClassOf ‘is conjugate acid of ’ some Y
OR
X is SubClassOf ‘is conjugate base of ’ some Y
BEGIN
ADD ‘has participant’ some X = has participant’
some Y
ADD ‘transports’ some X = transports’ some Y
ADD ‘has input’ some X = has input’ some Y
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These GCIs in BioChEBI allow the direct usage of
either acids or their conjugate bases in GO logical defi-
nitions, while keeping the original GO semantics. There
is no need for new grouping classes and identifiers and
the overhead they introduce. Also, we avoid the possible
logic inconsistencies by declaring the conjugate base/acid
ChEBI terms as equivalent.
As part of the release process for GO, a subset of Bio-
ChEBI is generated consisting of only the ChEBI terms
used by GO together with descendant classes (http://purl.
obolibrary.org/obo/go/extensions/chebi_import.owl). This
sub-ontology is itself imported by the extended version of
GO (http://purl.obolibrary.org/obo/go/extensions/go-plus.
owl) which includes the logical definitions.
Integration of reasoning into the GO
We use the ELK reasoner to automatically place GO
chemical process classes based on their logical definition
and placement in ChEBI. This can happen either at the
time of class creation, or alternatively after a new release
of ChEBI in which the placement of chemical entity clas-
ses moves. In either case, the procedure is as follows: the
reasoner is invoked via the OWL API (Application Pro-
grammer Interface) and the most specific superclasses
are obtained. The resulting relationship is asserted into
the main GO editors ontology as a SubClassOf axiom, and
this axiom is tagged with an axiom annotation marking
it as having been inferred by an automated procedure.
If a SubClassOf axiom has been tagged in this way from
a previous inference, and it is no longer a valid infer-
ence, then it is removed. This allows the GO chemical
process hierarchy to stay in sync with ChEBI. In both
cases, a report is created showing new automated links
added, and automated links previously added that have
been removed.
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